Clinical trial

Non-interventional, Prospective Study to Determine Prevalence of EGFR Mutations in Non-small Cell Lung Cancer

NCT04742192

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2021-03-04

PhaseN/A

Study timeline

Study start (actual)2021-03-04Date precision: day

Registry last updated2023-08-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small Cell Lung Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

SantiagoChile2 LimaPeru2 Buenos AiresArgentina1 AnkaraTurkey (Türkiye)1 SingaporeSingapore1 BangkokThailand1 CairoEgypt1 Mexico CityMexico City, Mexico1 MonterreyMexico1 GuadalajaraMexico1 BogotáColombia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04742192 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.